IBDEI0AM ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4953,1,5,0)
 ;;=5^Dermatographia
 ;;^UTILITY(U,$J,358.3,4953,2)
 ;;=^265291
 ;;^UTILITY(U,$J,358.3,4954,0)
 ;;=705.81^^39^400^6
 ;;^UTILITY(U,$J,358.3,4954,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4954,1,2,0)
 ;;=2^705.81
 ;;^UTILITY(U,$J,358.3,4954,1,5,0)
 ;;=5^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,4954,2)
 ;;=^96545
 ;;^UTILITY(U,$J,358.3,4955,0)
 ;;=459.89^^39^401^1
 ;;^UTILITY(U,$J,358.3,4955,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4955,1,2,0)
 ;;=2^459.89
 ;;^UTILITY(U,$J,358.3,4955,1,5,0)
 ;;=5^Ecchymosis Multiple
 ;;^UTILITY(U,$J,358.3,4955,2)
 ;;=^87910
 ;;^UTILITY(U,$J,358.3,4956,0)
 ;;=686.8^^39^401^2
 ;;^UTILITY(U,$J,358.3,4956,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4956,1,2,0)
 ;;=2^686.8
 ;;^UTILITY(U,$J,358.3,4956,1,5,0)
 ;;=5^Ecthyma
 ;;^UTILITY(U,$J,358.3,4956,2)
 ;;=^88097
 ;;^UTILITY(U,$J,358.3,4957,0)
 ;;=039.0^^39^401^6
 ;;^UTILITY(U,$J,358.3,4957,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4957,1,2,0)
 ;;=2^039.0
 ;;^UTILITY(U,$J,358.3,4957,1,5,0)
 ;;=5^Erythrasma
 ;;^UTILITY(U,$J,358.3,4957,2)
 ;;=^29822
 ;;^UTILITY(U,$J,358.3,4958,0)
 ;;=035.^^39^401^5
 ;;^UTILITY(U,$J,358.3,4958,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4958,1,2,0)
 ;;=2^035.
 ;;^UTILITY(U,$J,358.3,4958,1,5,0)
 ;;=5^Erysipelas
 ;;^UTILITY(U,$J,358.3,4958,2)
 ;;=^42012
 ;;^UTILITY(U,$J,358.3,4959,0)
 ;;=057.9^^39^401^8
 ;;^UTILITY(U,$J,358.3,4959,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4959,1,2,0)
 ;;=2^057.9
 ;;^UTILITY(U,$J,358.3,4959,1,5,0)
 ;;=5^Exanthem(Viral)
 ;;^UTILITY(U,$J,358.3,4959,2)
 ;;=^266599
 ;;^UTILITY(U,$J,358.3,4960,0)
 ;;=686.9^^39^401^3
 ;;^UTILITY(U,$J,358.3,4960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4960,1,2,0)
 ;;=2^686.9
 ;;^UTILITY(U,$J,358.3,4960,1,5,0)
 ;;=5^Ecthyma gangrenosum
 ;;^UTILITY(U,$J,358.3,4960,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,4961,0)
 ;;=757.39^^39^401^4
 ;;^UTILITY(U,$J,358.3,4961,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4961,1,2,0)
 ;;=2^757.39
 ;;^UTILITY(U,$J,358.3,4961,1,5,0)
 ;;=5^Epidermolysis bullosa acquisita
 ;;^UTILITY(U,$J,358.3,4961,2)
 ;;=^87938
 ;;^UTILITY(U,$J,358.3,4962,0)
 ;;=695.9^^39^401^7
 ;;^UTILITY(U,$J,358.3,4962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4962,1,2,0)
 ;;=2^695.9
 ;;^UTILITY(U,$J,358.3,4962,1,5,0)
 ;;=5^Erythroderma, exfoliative
 ;;^UTILITY(U,$J,358.3,4962,2)
 ;;=^123902
 ;;^UTILITY(U,$J,358.3,4963,0)
 ;;=709.09^^39^402^3
 ;;^UTILITY(U,$J,358.3,4963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4963,1,2,0)
 ;;=2^709.09
 ;;^UTILITY(U,$J,358.3,4963,1,5,0)
 ;;=5^Freckles
 ;;^UTILITY(U,$J,358.3,4963,2)
 ;;=Freckles^303313
 ;;^UTILITY(U,$J,358.3,4964,0)
 ;;=709.4^^39^402^2
 ;;^UTILITY(U,$J,358.3,4964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4964,1,2,0)
 ;;=2^709.4
 ;;^UTILITY(U,$J,358.3,4964,1,5,0)
 ;;=5^Foreign Body Reaction/Granuloma
 ;;^UTILITY(U,$J,358.3,4964,2)
 ;;=Foreign Body Reaction/Granuloma^271943
 ;;^UTILITY(U,$J,358.3,4965,0)
 ;;=698.4^^39^402^1
 ;;^UTILITY(U,$J,358.3,4965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4965,1,2,0)
 ;;=2^698.4
 ;;^UTILITY(U,$J,358.3,4965,1,5,0)
 ;;=5^Factitial Dermatitis
 ;;^UTILITY(U,$J,358.3,4965,2)
 ;;=^186786
 ;;^UTILITY(U,$J,358.3,4966,0)
 ;;=228.01^^39^403^1
 ;;^UTILITY(U,$J,358.3,4966,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4966,1,2,0)
 ;;=2^228.01
 ;;^UTILITY(U,$J,358.3,4966,1,5,0)
 ;;=5^Hemangioma Skin
 ;;^UTILITY(U,$J,358.3,4966,2)
 ;;=^267697
 ;;^UTILITY(U,$J,358.3,4967,0)
 ;;=705.83^^39^403^2
 ;;^UTILITY(U,$J,358.3,4967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4967,1,2,0)
 ;;=2^705.83
 ;;^UTILITY(U,$J,358.3,4967,1,5,0)
 ;;=5^Hidradentitis Suppuritiva
